American Healthcare REIT (AHR) Price to Sales (2024 - 2026)

American Healthcare REIT (AHR) has reported Price to Sales for 3 consecutive years, with 15.06 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Price to Sales rose 31.9% year-over-year to 15.06; the trailing twelve-month figure through Jun 2026 stood at 4.06 (up 40.84% YoY), and the FY2025 full-year result was 3.87, up 115.9% from the prior year.
• Price to Sales grew to 15.06 in Q2 2026 per AHR's latest filing, from 13.76 in the prior quarter.
• Across five years, Price to Sales topped out at 15.06 in Q2 2026 and bottomed at 3.81 in Q2 2024.
• Historically, Price to Sales has averaged 9.88 across 3 years, with a median of 10.18 in 2025.
• The sharpest annual moves came in 2025 and 2026: Price to Sales jumped 199.5% in 2025, then jumped 31.9% in 2026.
• Over 3 years, Price to Sales stood at 6.84 in 2024, then soared by 111.72% to 14.48 in 2025, then grew by 3.97% to 15.06 in 2026.
• According to Business Quant data, Price to Sales over the past three periods registered 15.06, 13.76, and 14.48 for Q2 2026, Q1 2026, and Q4 2025 respectively.